Kapp, Ursula
Cancer Prevention II
I. Cancer Prevention and Health Politics
1. Do We Make Optimal Use of the Potential of Cancer Prevention?
Peter Greenwald, Barbara K. Dunn
2. Predictors of Successful Cancer Prevention Programs
Franz Porzsolt, Anita Kirner, Robert M. Kaplan
3. Cancer Prevenpinon in the Developing World: Mission Impossible?
Franco Cavalli
I. Cancer Prevention and Health Politics
4. Is Cancer Prevention Ever Going to Be Profitable?
Thomas D. Szucs, Konstantin J. Dedes
5. Energy Metabolism, Cancer Risk, and Cancer Prevention
Michael Pollak
6. Promises and Limitations of Biomarkers
David F. Ransohoff
7. The EPIC Study: An Update
Paolo Vineis, Elio Riboli
8. Anti-angiogenic properties of Chemopreventive Drugs: Fenretinide as a Prototype.
Ilaria Sogno, Roberta Venè, Cristina Sapienza, Nicoletta Ferrari, Francesca Tosetti, Adriana Albini
9. Retinoids and Breast Cancer Prevention
Bernardo Bonanni, Matteo Lazzeroni
10. Cancer Prevention by Vaccination Against Hepatitis B
Mei-Hwei Chang
V. Cancer Prevention and Target Organs I: Breast Cancer
11. Energy Restriction for Breast Cancer Prevention
Anthony Howell, Mary Chapman, Michelle Harvie
12. The Use of Tamoxifen and Raloxifene for the Prevention of Breast Cancer
D. Lawrence Wickerham, Joseph P. Costantino, Victor G. Vogel, Walter M. Cronin, Reena S. Cecchini, Leslie G. Ford, Norman Wolmark
13. Prevention of ER-Negative Breast Cancer
Yuxin Li, Powel H. Brown
14. EHxoorgmeonnoeuss, aMnadmEmndooggraepnhoiucs Density and Breast Cancer Risk: Can Mammographic Density Be Considered an Intermediate Marker of Risk?
Susen Becker, Rudolf Kaaks
VI. Cancer Prevention and Target Organs II: Cancer of the Digestive Tract
15. Chemoprevention of Oesophageal Cancer and the AspECT Trial
Debasish Das, Andrew P. Chilton, Janusz A. Jankowski
VII. Cancer Prevention and Target Organs III: Prostate Cancer
16. Review of Diagnostic Markers for Prostate Cancer 16
Fritz H. Schröder
17. Seleneium and Vitamin E Cancer Prevention Trial: A Nutrient Approach to Prostate Cancer Prevention
Barbara K. Dunn, Anne Ryan, Leslie G. Ford
18. Prostate Cancer Prevention by Short-Term Anti-androgens: The Rationale Behind Design of Pilot Studies
Tim Oliver, Attila Lorincz, Jack Cuzick
VIII. Cancer Prevention and Target Organs III: Prostate Cancer
19. Anti-angiogenic Activity of a Novel Class of Chemopreventive Compounds: Oleanic Acid Terpenoids
Ilaria Sogno, Nicola Vannini, Girieca Lorusso, Rosaria Cammarota, Douglas M. Noonan, Luca Generoso, Michael B. Sporn, Adriana Albini
IX. Aspirin and NSAIDs in Cancer Prevention: Attempts at an International Consensus
20. Pharmacologic Effects of NSAIDs and Implications for the Risks and Benefits of Long-Term Prophylactic Use of Aspirin to Prevent Cancer
Michael J. Thun, Bonny Blackard
21. Aspirin and NSAIDs for the Prevention of Colorectal Cancer
John A. Baron
22. Aspirin and Cancer Risk: A Summary Review to 2007
Cristina Bosetti, Silvano Gallus, Carlo La Vecchia
Nyckelord: MEDICAL / Public Health MED078000
- Författare
- Kapp, Ursula
- Otto, Florian
- Senn, Hans-Jörg
- Utgivare
- Springer
- Utgivningsår
- 2009
- Språk
- en
- Utgåva
- 1
- Kategori
- Hälsa, skönhet, mode
- Format
- E-bok
- eISBN (PDF)
- 9783540692973